Frank A Holler - Net Worth and Insider Trading

Frank A Holler Net Worth

The estimated net worth of Frank A Holler is at least $5 Million dollars as of 2024-11-13. Frank A Holler is the Director of Xenon Pharmaceuticals Inc and owns about 118,955 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $5 Million. Details can be seen in Frank A Holler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frank A Holler has not made any transactions after 2019-09-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Frank A Holler

To

Frank A Holler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Frank A Holler owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .

Click here to see the complete history of Frank A Holler’s form 4 insider trades.

Insider Ownership Summary of Frank A Holler

Ticker Comapny Transaction Date Type of Owner
XENE Xenon Pharmaceuticals Inc 2019-09-20 director

Frank A Holler Latest Holdings Summary

Frank A Holler currently owns a total of 1 stock. Frank A Holler owns 118,955 shares of Xenon Pharmaceuticals Inc (XENE) as of September 20, 2019, with a value of $5 Million.

Latest Holdings of Frank A Holler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XENE Xenon Pharmaceuticals Inc 2019-09-20 118,955 43.36 5,157,889

Holding Weightings of Frank A Holler


Frank A Holler Form 4 Trading Tracker

According to the SEC Form 4 filings, Frank A Holler has made a total of 0 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 12,806 shares on September 20, 2019, which brought Frank A Holler around $119,352.

Insider Trading History of Frank A Holler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Frank A Holler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Frank A Holler Ownership Network

Ownership Network List of Frank A Holler

No Data

Ownership Network Relation of Frank A Holler

Insider Network Chart

Frank A Holler Owned Company Details

What does Xenon Pharmaceuticals Inc do?

Who are the key executives at Xenon Pharmaceuticals Inc?

Frank A Holler is the director of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .

Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary

Over the past 18 months, Frank A Holler made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .

In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.

Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xenon Pharmaceuticals Inc Insider Transactions

No Available Data

Frank A Holler Mailing Address

Above is the net worth, insider trading, and ownership report for Frank A Holler. You might contact Frank A Holler via mailing address: Suite 707, 1177 West Hastings St, Vancover British Col A1.